Provision of Haemodialysis and Plasma Pheresis In Centre Equipment and Associated Consumables

Concepts

• renal dialysis consumables
• cardiff
• uhw
• renal consumables
• provision of haemodialysis
• david thomas haemodialysis unit
• plasma pheresis
• outpatient haemodialysis
• chronic haemodialysis patients
• home haemodialysis

Location

Cardiff

Description

The NHS Wales Shared Services Partnership, hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board who are seeking to to establish a contract for the provision of Haemodialysis and Plasma Pheresis In Centre Equipment and Associated Consumables. The Nephrology and Transplant Directorate at the University Hospital of Wales (UHW) serves a population of approximately 1.4 million people in South East Wales, providing a complete range of diagnostic and therapeutic services including dialysis and transplantation to adult patients. Our take-on rate for Renal Replacement Therapy (RRT) has recently been approximately 120 patients per million per annum, and approximately 700 patients receive a dialysis therapy at any one time. Our program emphasises the benefits of home therapies, and currently there are approximately 35 patients receiving home haemodialysis with a further 60 on peritoneal therapies. Outpatient Haemodialysis is delivered through a network of Satellite units across the region, supported by The David Thomas Haemodialysis Unit (DTU) on-site at UHW. DTU has recently been extensively refurbished and has seven stations, providing capacity for up to 28 patients per week. The unit focuses on providing outpatient dialysis for patients with complex needs who require specific care best provided on a Hospital site, and also treats Chronic Haemodialysis patients who may be admitted to UHW with non-renal problems. Inpatient dialysis is provided to the Directorate’s patients on a 27 bedded Nephrology ward (Ward B5), and on the 20-bedded Cardiff Transplant Unit (CTU) at UHW. Therapies are provided to Chronic Haemodialysis patients, patients with Acute Kidney Injury, and patients in the pre-and post-transplant settings. Plasma exchange is provided where clinically indicated in the management of acute vasculitides, and plasmapheresis may be provided as part of the ABO Incompatible Transplant program as well as in the management of Acute Graft Rejection.

Lot Division

Renewal Options

The contract will have an option to extend for up two years at the sole discretion of the Health Board which is included in the months duration within this notice.

CPV Codes

• 33181520 - Renal dialysis consumables
• 33181500 - Renal consumables

Indicators

• Bids should cover one or more lots.
• Bids should cover the whole contract.
• Renewals are available.
• Award on basis of price and quality.

Other Information

Please note additional information on this procurement: 1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract. 2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the tender and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms. 3. The Contracting Authority will not accept completed tenders after the stated closing date. 4. All documents to be priced (where applicable) in sterling and all payments made in sterling. 5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders. 6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board. 7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_85384 for all tender documentation. NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=107181 (WA Ref:107181) The buyer considers that this contract is suitable for consortia.